- TG Therapeutics press release (NASDAQ:TGTX): Q2 GAAP EPS of $0.04 beats by $0.09.
- Revenue of $73.47M (+357.2% Y/Y) beats by $7.58M.
TG Therapeutics GAAP EPS of $0.04 beats by $0.09, revenue of $73.47M beats by $7.58M
News / Analytics / Reviews